Literature DB >> 22980739

Chemical oxidation of a redox-active, ferrocene-containing cationic lipid: influence on interactions with DNA and characterization in the context of cell transfection.

Burcu S Aytar1, John P E Muller, Sharon Golan, Yukishige Kondo, Yeshayahu Talmon, Nicholas L Abbott, David M Lynn.   

Abstract

We report an approach to the chemical oxidation of a ferrocene-containing cationic lipid [bis(11-ferrocenylundecyl)dimethylammonium bromide, BFDMA] that provides redox-based control over the delivery of DNA to cells. We demonstrate that BFDMA can be oxidized rapidly and quantitatively by treatment with Fe(III)sulfate. This chemical approach, while offering practical advantages compared to electrochemical methods used in past studies, was found to yield BFDMA/DNA lipoplexes that behave differently in the context of cell transfection from lipoplexes formed using electrochemically oxidized BFDMA. Specifically, while lipoplexes of the latter do not transfect cells efficiently, lipoplexes of chemically oxidized BFDMA promoted high levels of transgene expression (similar to levels promoted by reduced BFDMA). Characterization by SANS and cryo-TEM revealed lipoplexes of chemically and electrochemically oxidized BFDMA to both have amorphous nanostructures, but these lipoplexes differed significantly in size and zeta potential. Our results suggest that differences in zeta potential arise from the presence of residual Fe(2+) and Fe(3+) ions in samples of chemically oxidized BFDMA. Addition of the iron chelating agent EDTA to solutions of chemically oxidized BFDMA produced samples functionally similar to electrochemically oxidized BFDMA. These EDTA-treated samples could also be chemically reduced by treatment with ascorbic acid to produce samples of reduced BFDMA that do promote transfection. Our results demonstrate that entirely chemical approaches to oxidation and reduction can be used to achieve redox-based 'on/off' control of cell transfection similar to that achieved using electrochemical methods.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22980739      PMCID: PMC3459070          DOI: 10.1016/j.jcis.2012.07.083

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  26 in total

Review 1.  Chemical approaches to triggerable lipid vesicles for drug and gene delivery.

Authors:  Xin Guo; Francis C Szoka
Journal:  Acc Chem Res       Date:  2003-05       Impact factor: 22.384

2.  Addition of ascorbic acid to the extracellular environment activates lipoplexes of a ferrocenyl lipid and promotes cell transfection.

Authors:  Burcu S Aytar; John P E Muller; Sharon Golan; Shinichi Hata; Hiro Takahashi; Yukishige Kondo; Yeshayahu Talmon; Nicholas L Abbott; David M Lynn
Journal:  J Control Release       Date:  2011-09-22       Impact factor: 9.776

3.  Photo-assisted gene delivery using light-responsive catanionic vesicles.

Authors:  Yu-Chuan Liu; Anne-Laure M Le Ny; Judith Schmidt; Yeshayahu Talmon; Bradley F Chmelka; C Ted Lee
Journal:  Langmuir       Date:  2009-05-19       Impact factor: 3.882

Review 4.  How to screen non-viral gene delivery systems in vitro?

Authors:  Ethlinn V B van Gaal; Roel van Eijk; Ronald S Oosting; Robbert Jan Kok; Wim E Hennink; Daan J A Crommelin; Enrico Mastrobattista
Journal:  J Control Release       Date:  2011-05-07       Impact factor: 9.776

5.  Synthesis, characterization, and in vitro transfection activity of charge-reversal amphiphiles for DNA delivery.

Authors:  Xiao-Xiang Zhang; Carla A H Prata; Jason A Berlin; Thomas J McIntosh; Philippe Barthelemy; Mark W Grinstaff
Journal:  Bioconjug Chem       Date:  2011-04-01       Impact factor: 4.774

6.  Reducible cationic lipids for gene transfer.

Authors:  B Wetzer; G Byk; M Frederic; M Airiau; F Blanche; B Pitard; D Scherman
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

7.  Influence of biological media on the structure and behavior of ferrocene-containing cationic lipid/DNA complexes used for DNA delivery.

Authors:  Sharon Golan; Burcu S Aytar; John P E Muller; Yukishige Kondo; David M Lynn; Nicholas L Abbott; Yeshayahu Talmon
Journal:  Langmuir       Date:  2011-05-02       Impact factor: 3.882

8.  Ferrocene-containing cationic lipids: influence of redox state on cell transfection.

Authors:  Nicholas L Abbott; Christopher M Jewell; Melissa E Hays; Yukishige Kondo; David M Lynn
Journal:  J Am Chem Soc       Date:  2005-08-24       Impact factor: 15.419

9.  Lipoplexes formed by DNA and ferrocenyl lipids: effect of lipid oxidation state on size, internal dynamics, and zeta-potential.

Authors:  Melissa E Hays; Christopher M Jewell; Yukishige Kondo; David M Lynn; Nicholas L Abbott
Journal:  Biophys J       Date:  2007-08-24       Impact factor: 4.033

10.  Chemical activation of lipoplexes formed from DNA and a redox-active, ferrocene-containing cationic lipid.

Authors:  Christopher M Jewell; Melissa E Hays; Yukishige Kondo; Nicholas L Abbott; David M Lynn
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

View more
  4 in total

Review 1.  Stimuli-responsive liposomes for drug delivery.

Authors:  Y Lee; D H Thompson
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-15

2.  Spatial control of cell transfection using soluble or solid-phase redox agents and a redox-active ferrocenyl lipid.

Authors:  Burcu S Aytar; John P E Muller; Yukishige Kondo; Nicholas L Abbott; David M Lynn
Journal:  ACS Appl Mater Interfaces       Date:  2013-08-28       Impact factor: 9.229

3.  Influence of the Phase State of Self-Assembling Redox Mediators on their Electrochemical Activity.

Authors:  John P E Muller; Burcu S Aytar; Yukishige Kondo; David M Lynn; Nicholas L Abbott
Journal:  AIChE J       Date:  2014-04-01       Impact factor: 3.993

Review 4.  Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment.

Authors:  Ricardo Gaspar; Filipe Coelho; Bruno F B Silva
Journal:  Molecules       Date:  2020-10-28       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.